Information Library
Results for: Oncology - Phase II/III
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Quintiles Forms New Biomarker Research and Development Company
Press Release — January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.
-
ASCO 2012
Event — Conference Date(s): June 1 - June 5, 2012
Location: Chicago, IL McCormick Place
Booth Number: 2062
-
Energizing Enrollment
Case Study — October 4, 2011
The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. -
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
White Paper — June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Recruiting Trust
Case Study — March 16, 2011
Quintiles enrolls 2 cancer trials, 2 times faster than projected -
Clinical – Smarter Trials, Accelerated Outcomes
Brochure — February 16, 2011
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
Exclusive Report From Scientific American
Hear from the Experts — November 9, 2010
In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today. -
Oncology Drug Development and Value-Based Medicine
White Paper — November 5, 2010
This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices. -
From Biomarkers to Diagnostics - The Road to Success
White Paper — October 18, 2010
In the second installment of a two-part series, Eric Groves, Jason Hill and Christopher Ung walk through the challenges associated with drug-diagnostic co-development, addressing potential pitfalls and areas of opportunity. -
Management of Tissue Specimens for Oncology Drug Development in China
Presentation — October 1, 2010
Download Patty James of Quintiles recent presentation Management of Tissue Specimens for Oncology Drug Development in China from the Clinical Development of Cancer Drugs in China